Global Bioinformatics Market Outlook

Table of Contents

1. Analyst View

2. Emergence of Bioinformatics

• 2.1 Growth in Information Technology & Internet
• 2.2 Rising Costs & Timelines in Drug Delivery
• 2.3 Dwindling Drug Pipelines & Patent Expirations
• 2.4 Efficient Storage & Analysis of Research Data

3. Global Bioinformatics Market

• 3.1 Current & Future Scenario
• 3.2 By Region
  • 3.2.1 US
  • 3.2.2 Europe
  • 3.2.3 Asia-Pacific
    • 3.2.3.1 Japan
    • 3.2.3.2 India
    • 3.2.3.3 China
    • 3.2.3.4 South Korea
    • 3.2.3.5 Taiwan
    • 3.2.3.6 Singapore
    • 3.2.3.7 Australia
• 3.3 By Segment
  • 3.3.1 Analysis Software & Services Market
  • 3.3.2 Content Market
  • 3.3.3 IT Infrastructure & Other Services Market
• 3.4 By Application
  • 3.4.1 Genomics
  • 3.4.2 Proteomics
  • 3.4.3 Pharmacogenomics
  • 3.4.4 Drug Discovery & Cheminformatics

4. Industry Analysis

• 4.1 Opportunities
  • 4.1.1 Pharmaceutical & Biopharmaceutical Industry
  • 4.1.2 Agri-biotechnology & Industrial Biotechnology Industry
  • 4.1.3 Bioinformatics Outsourcing
  • 4.1.4 Drug Delivery Market
• 4.2 Challenges
  • 4.2.1 Lack of Standardization
  • 4.2.2 Patent-related Issues
  • 4.2.3 Limited User Base

5. Key Players

• 5.1 Accelrys, Inc.
• 5.2 Affymetrix, Inc.
• 5.3 Applied Biosystems Group
• 5.4 Celera Genomics Group
• 5.5 Ciphergen Biosystems
• 5.6 Compugen Ltd.
• 5.7 CuraGen Corporation
• 5.8 Gene Logic Inc.
• 5.9 IBM Life Sciences
• 5.10 Incyte Corporation
• 5.11 Tripos, Inc.

List of Figures:

• Figure 2-1: Reduction in Time & Cost (%) by Using Computer Aided Drug Design Method
• Figure 2-2: Worldwide - Forecast for Number of Drugs Facing Patent Expirations* (2007-2011)
• Figure 2-3: Worldwide - Forecast for Loss due to Drug Patent Expirations* (in Billion US$), 2007-2011
• Figure 3-1: Worldwide - Bioinformatics Market (in Million US$), 2002-2006E
• Figure 3-2: Worldwide - Forecast for Bioinformatics Market (in Million US$), 2007-2010
• Figure 3-3: US - Share in Global Bioinformatics Market (%), 2007F
• Figure 3-4: Europe - Bioinformatics Market (in Million US$), 2004 & 2006
• Figure 3-5: Europe - Percentage of R&D Spending & Drugs in Pipeline by Company Size, 2004
• Figure 3-6: Europe - Forecast for Bioinformatics Market (in Million US$), 2007-2013
• Figure 3-7: Japan - Bioinformatics Market (in Billion Yen), 2001-2003
• Figure 3-8: India - Bioinformatics Market (in Rs Crore), 2002-03 to 2006-07
• Figure 3-9: India - Share of Exports & Domestic Market in Bioinformatics Industry (%), 2006-07
• Figure 3-10: South Korea - Bioinformatics Market, Exports & Imports (in ‘000 US$), 2004
• Figure 3-11: Taiwan - Bioinformatics Market (in Million US$), 2001-2003E & 2006E
• Figure 3-12: Taiwan - Bioinformatics Market Imports (in Million US$), 2001-2003E & 2006E
• Figure 3-13: Australia - Biotech Companies by Sector (%), 2006
• Figure 3-14: Worldwide - Bioinformatics Market by Segment (%), 2006E
• Figure 3-15: Worldwide - Forecast for Bioinformatics Market by Segment (%), 2010
• Figure 3-16: Worldwide - Analysis Software & Services Market (in Million US$), 2005 & 2006E
• Figure 3-17: Worldwide - Forecast for Analysis Software & Services Market (in Million US$), 2007 -2010
• Figure 3-18: Worldwide - Analysis Software & Services Market by Application (%), 2006E
• Figure 3-19: Worldwide - Forecast for Analysis Software & Services Market by Application (%), 2009
• Figure 3-20: Worldwide - Content Market (in Million US$), 2005 & 2006E
• Figure 3-21: Worldwide - Forecast for Content Market (in Million US$), 2007-2010
• Figure 3-22: Worldwide - IT Infrastructure & Other Services Market (in Million US$), 2005 & 2006E
• Figure 3-23: Worldwide - Forecast for IT Infrastructure & Other Services Market (in Million US$), 2007-2010
• Figure 3-24: Worldwide - Bioinformatics Market by Application (%), 2001
• Figure 3-25: Worldwide - Genomics Market (in Billion US$) 2002 & 2006E
• Figure 3-26: Worldwide - Forecast for Genomics Market (in Billion US$), 2007-2009
• Figure 3-27: Worldwide - DNA Sequencing & Proteomics Market (in Billion US$), 2004-2006E
• Figure 3-28: Worldwide - Forecast for DNA Sequencing & Proteomics Market (in Billion US$), 2007-2009
• Figure 3-29: Worldwide - Application of Proteomics in Bioinformatics Market (in Million US$), 2005-2007
• Figure 3-30: Worldwide - Pharmacogenomics Market by Core Segment (in Million US$), 2004-2006E
• Figure 3-31: Worldwide - Forecast for Pharmacogenomics Market by Core Segment (in Million US$), 2007-2009
• Figure 3-32: Worldwide - Pharmacogenomics Market (in Million US$), 2004-2006E
• Figure 3-33: Worldwide - Forecast for Pharmacogenomics Market (in Million US$), 2007-2009
• Figure 3-34: Worldwide - Application of Pharmacogenomics in Bioinformatics Market (in Million US$), 2005-2007E
• Figure 3-35: Worldwide - Drug Discovery Expenditure (in Billion US$), 2002 & 2006E
• Figure 4-1: Worldwide - Drug Delivery Market (in Billion US$), 2005 & 2006E
• Figure 4-2: Worldwide - Forecast for Drug Delivery Market (in Billion US$), 2007-2010

List of Tables:

• Table 3-1: Growth in Key Bioinformatics Databases (December 2004 & December 2005)
• Table 5-1: Accelrys, Inc. - Key Financials (in Million US$), 2005-2007
• Table 5-2: Affymetrix, Inc. - Key Financials (in Million US$), 2004-2006
• Table 5-3: Applied Biosystems Group - Key Financials (in Million US$), 2004-2006
• Table 5-4: Celera Genomics Group - Key Financials (in Million US$), 2004-2006
• Table 5-5: Ciphergen Biosystems - Key Financials (in Millions US$), 2004-2006
• Table 5-6: Compugen Ltd. - Key Financials (in Million US$), 2004-2006
• Table 5-7: CuraGen Corporation - Key Financials (in Million US$), 2004-2006
• Table 5-8: Gene Logic Inc. - Key Financials (in Million US$), 2004-2006
• Table 5-9: Incyte Corporation - Key Financials (in Million US$), 2004-2006
• Table 5-10: Tripos, Inc. - Key Financials (in Million US$), 2004-2006